These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype. Lankisch TO; Moebius U; Wehmeier M; Behrens G; Manns MP; Schmidt RE; Strassburg CP Hepatology; 2006 Nov; 44(5):1324-32. PubMed ID: 17058217 [TBL] [Abstract][Full Text] [Related]
4. Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. Urawa N; Kobayashi Y; Araki J; Sugimoto R; Iwasa M; Kaito M; Adachi Y Oncol Rep; 2006 Oct; 16(4):801-6. PubMed ID: 16969497 [TBL] [Abstract][Full Text] [Related]
5. Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Köhle C; Möhrle B; Münzel PA; Schwab M; Wernet D; Badary OA; Bock KW Biochem Pharmacol; 2003 May; 65(9):1521-7. PubMed ID: 12732365 [TBL] [Abstract][Full Text] [Related]
6. Combined UGT1A1 and UGT1A7 variant alleles are associated with increased risk of Gilbert's syndrome in Taiwanese adults. Teng HC; Huang MJ; Tang KS; Yang SS; Tseng CS; Huang CS Clin Genet; 2007 Oct; 72(4):321-8. PubMed ID: 17850628 [TBL] [Abstract][Full Text] [Related]
7. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Gagné JF; Montminy V; Belanger P; Journault K; Gaucher G; Guillemette C Mol Pharmacol; 2002 Sep; 62(3):608-17. PubMed ID: 12181437 [TBL] [Abstract][Full Text] [Related]
8. UGT1A1, UGT1A6 and UGT1A7 genetic analysis: repercussion for irinotecan pharmacogenetics in the São Miguel Island Population (Azores, Portugal). Pacheco PR; Brilhante MJ; Ballart C; Sigalat F; Polena H; Cabral R; Branco CC; Mota-Vieira L Mol Diagn Ther; 2009; 13(4):261-8. PubMed ID: 19712005 [TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter. Hsieh TY; Shiu TY; Huang SM; Lin HH; Lee TC; Chen PJ; Chu HC; Chang WK; Jeng KS; Lai MM; Chao YC Pharmacogenet Genomics; 2007 Apr; 17(4):229-36. PubMed ID: 17496722 [TBL] [Abstract][Full Text] [Related]
10. Alteration of the function of the UDP-glucuronosyltransferase 1A subfamily by cytochrome P450 3A4: different susceptibility for UGT isoforms and UGT1A1/7 variants. Ishii Y; Koba H; Kinoshita K; Oizaki T; Iwamoto Y; Takeda S; Miyauchi Y; Nishimura Y; Egoshi N; Taura F; Morimoto S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H Drug Metab Dispos; 2014 Feb; 42(2):229-38. PubMed ID: 24255116 [TBL] [Abstract][Full Text] [Related]
11. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. Villeneuve L; Girard H; Fortier LC; Gagné JF; Guillemette C J Pharmacol Exp Ther; 2003 Oct; 307(1):117-28. PubMed ID: 12944498 [TBL] [Abstract][Full Text] [Related]
13. TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert's syndrome. Sampietro M; Lupica L; Perrero L; Romano R; Molteni V; Fiorelli G Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):194-8. PubMed ID: 9675658 [TBL] [Abstract][Full Text] [Related]
14. Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases. Burchell B; Soars M; Monaghan G; Cassidy A; Smith D; Ethell B Toxicol Lett; 2000 Mar; 112-113():333-40. PubMed ID: 10720749 [TBL] [Abstract][Full Text] [Related]
15. Genotype frequencies of UDP-glucuronosyltransferase 1A1 promoter gene polymorphism in the population of healthy Croatian pre-scholars. Marinković N; Pasalić D; Grsković B; Ferencak G; Honović L; Rukavina AS Coll Antropol; 2008 Sep; 32(3):725-9. PubMed ID: 18982743 [TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of the UDP-glucuronosyltransferase 1A7 gene and irinotecan toxicity in Japanese cancer patients. Ando M; Ando Y; Sekido Y; Ando M; Shimokata K; Hasegawa Y Jpn J Cancer Res; 2002 May; 93(5):591-7. PubMed ID: 12036456 [TBL] [Abstract][Full Text] [Related]
17. Shared regulation of UGT1A7 by hepatocyte nuclear factor (HNF) 1alpha and HNF4alpha. Ehmer U; Kalthoff S; Lankisch TO; Freiberg N; Manns MP; Strassburg CP Drug Metab Dispos; 2010 Jul; 38(7):1246-57. PubMed ID: 20406851 [TBL] [Abstract][Full Text] [Related]
18. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment. Lankisch TO; Behrens G; Ehmer U; Möbius U; Rockstroh J; Wehmeier M; Kalthoff S; Freiberg N; Manns MP; Schmidt RE; Strassburg CP J Hepatol; 2009 May; 50(5):1010-8. PubMed ID: 19303655 [TBL] [Abstract][Full Text] [Related]
19. Rapid allelic discrimination by TaqMan PCR for the detection of the Gilbert's syndrome marker UGT1A1*28. Ehmer U; Lankisch TO; Erichsen TJ; Kalthoff S; Freiberg N; Wehmeier M; Manns MP; Strassburg CP J Mol Diagn; 2008 Nov; 10(6):549-52. PubMed ID: 18832463 [TBL] [Abstract][Full Text] [Related]